Literature DB >> 18634985

Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.

Markus Juonala1, Jorma S A Viikari, Mika Kähönen, Tiina Solakivi, Hans Helenius, Antti Jula, Jukka Marniemi, Leena Taittonen, Tomi Laitinen, Tapio Nikkari, Olli T Raitakari.   

Abstract

OBJECTIVES: The aim of this study was to determine whether apolipoproteins (apo) B and A-I measured in childhood and adolescence predict atherosclerosis in adulthood.
BACKGROUND: Exposure to dyslipidemia in childhood predicts the development of atherosclerosis. Apolipoproteins B and A-I might be good markers of atherogenic dyslipidemia, but there is a paucity of information concerning their importance in childhood.
METHODS: Apolipoproteins B and A-I, low-density lipoprotein (LDL)-cholesterol, high-density lipoprotein (HDL)-cholesterol, triglycerides, blood pressure, obesity, insulin, C-reactive protein, and smoking were assessed in 1980 and 2001 among 879 subjects in the Cardiovascular Risk in Young Finns Study (ages 3 to 18 years at baseline). Carotid artery intima-media thickness (IMT) and brachial artery flow-mediated dilation (FMD) were measured in 2001 at the age of 24 to 39 years.
RESULTS: In subjects ages 12 to 18 years at baseline, apoB and apoB/apoA-I ratio were directly (p < 0.001) related and apoA-I was inversely (p = 0.01) related with adulthood IMT. In subjects ages 3 to 18 years at baseline, apoB (p = 0.02) and the apoB/apoA-I ratio (p < 0.001) were inversely related and apoA-I (p = 0.003) was directly related to adulthood FMD. These relations were not altered when the effects of nonlipid risk factors and adulthood apolipoproteins were taken into account. The apoB/apoA-I ratio measured in adolescence was superior to LDL/HDL ratio (c-values, 0.623 vs. 0.569, p = 0.03) in predicting increased IMT in adulthood (IMT >or=90th percentile and/or carotid plaque).
CONCLUSIONS: Apolipoproteins B and A-I measured in children and adolescents reflect a lipoprotein profile predisposing to the development of subclinical atherosclerosis in adulthood. These markers might have value in pediatric lipid risk assessment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18634985     DOI: 10.1016/j.jacc.2008.03.054

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  30 in total

1.  Association between serum cholesterol and eating behaviours during early childhood: a cross-sectional study.

Authors:  Navindra Persaud; Jonathon L Maguire; Gerald Lebovic; Sarah Carsley; Marina Khovratovich; Janis A Randall Simpson; Brian W McCrindle; Patricia C Parkin; Catherine Birken
Journal:  CMAJ       Date:  2013-06-17       Impact factor: 8.262

Review 2.  Arterial compliance in obese children: implications for cardiovascular health.

Authors:  Jeanie B Tryggestad; Kevin R Short
Journal:  Exerc Sport Sci Rev       Date:  2014-10       Impact factor: 6.230

3.  Apolipoprotein B is associated with carotid atherosclerosis progression independent of individual cholesterol measures in a 9-year prospective study of Multi-Ethnic Study of Atherosclerosis participants.

Authors:  Brian T Steffen; Weihua Guan; Alan T Remaley; James H Stein; Mathew C Tattersall; Joel Kaufman; Michael Y Tsai
Journal:  J Clin Lipidol       Date:  2017-07-12       Impact factor: 4.766

4.  Association of apolipoprotein B, LDL-C and vascular stiffness in adolescents with type 1 diabetes.

Authors:  Petter Bjornstad; Nhung Nguyen; Christina Reinick; David M Maahs; Franziska K Bishop; Scott A Clements; Janet K Snell-Bergeon; Rachel Lieberman; Laura Pyle; Stephen R Daniels; R Paul Wadwa
Journal:  Acta Diabetol       Date:  2014-12-25       Impact factor: 4.280

5.  High prevalence of subclinical atherosclerosis in Brazilian postmenopausal women with low and intermediate risk by Framingham score.

Authors:  Ana Claudia Gomes Pereira Petisco; Jorge Eduardo Assef; Carlos Alberto de Jesus; Mohamed Hassan Saleh; Jose Eduardo Martins Barbosa; David Costa de Souza Le Bihan; Ibraim Masciarelli França Pinto; Simone Rolim Fernandes Fontes Pedra; Rodrigo Bellio de Mattos Barretto; Amanda Guerra de Moraes Rego Sousa
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-20       Impact factor: 2.357

Review 6.  When and how to start prevention of atherosclerosis? Lessons from the Cardiovascular Risk in the Young Finns Study and the Special Turku Coronary Risk Factor Intervention Project.

Authors:  Costan G Magnussen; Harri Niinikoski; Markus Juonala; Mika Kivimäki; Tapani Rönnemaa; Jorma S A Viikari; Olli Simell; Olli T Raitakari
Journal:  Pediatr Nephrol       Date:  2011-08-30       Impact factor: 3.714

Review 7.  Vascular health in children and adolescents: effects of obesity and diabetes.

Authors:  Kevin R Short; Piers R Blackett; Andrew W Gardner; Kenneth C Copeland
Journal:  Vasc Health Risk Manag       Date:  2009-11-16

8.  Excessive TV viewing and cardiovascular disease risk factors in adolescents. The AVENA cross-sectional study.

Authors:  David Martinez-Gomez; J Pablo Rey-López; Palma Chillón; Sonia Gómez-Martínez; Germán Vicente-Rodríguez; Miguel Martín-Matillas; Miguel Garcia-Fuentes; Manuel Delgado; Luis A Moreno; Oscar L Veiga; Joey C Eisenmann; Ascension Marcos
Journal:  BMC Public Health       Date:  2010-05-25       Impact factor: 3.295

9.  Relation of Combined Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B With Atherosclerosis in Adults With Type 1 Diabetes Mellitus.

Authors:  Petter Bjornstad; Robert H Eckel; Laura Pyle; Marian Rewers; David M Maahs; Janet K Snell-Bergeon
Journal:  Am J Cardiol       Date:  2015-07-16       Impact factor: 2.778

Review 10.  Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention.

Authors:  Jesús Millán; Xavier Pintó; Anna Muñoz; Manuel Zúñiga; Joan Rubiés-Prat; Luis Felipe Pallardo; Luis Masana; Alipio Mangas; Antonio Hernández-Mijares; Pedro González-Santos; Juan F Ascaso; Juan Pedro-Botet
Journal:  Vasc Health Risk Manag       Date:  2009-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.